A loophole in FDA processes means older drugs like the ones in oral decongestants weren’t properly tested. Here’s how we learned the most popular one doesn’t work
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Kenvue Inc. .
/PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Kenvue, Inc. ("Kenvue" or the "Company") (NYSE: KVUE) and certain.